Company Description
Loath to be stuck on one thing, 3M makes everything from masking tape to asthma inhalers. The company has six operating segments: display and...
Key 3M Financials
| Company Type | Public - NYSE: MMM Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $24,462.0 |
| 2007 Employees | 76,239 |
More 3M Financials (11 pages)
Latest 3M Jobs powered by Monster.com
- Client Support Analyst
- Technical Manager
- New Ulm Process Engineer
Rankings
- #100 in FORTUNE 500
- S&P 500
- Dow Jones Industrials
- #137 in FT Global 500
Competition
Competitive Landscape for Chemical Manufacturing - Industrial
Demand depends on the overall strength of the US economy, because most industrial chemicals are used in the manufacture of more-complicated products like fibers, plastics, paints, and paper. The...
Read more about 3M's competition across multiple industries
Top 3M Competitors
Sponsored Links
The Business Directory
3M Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, President, and CEO | George W. Buckley | Network | E-mail |
| EVP Research and Development and CTO | Frederick J. Palensky | Network | E-mail |
| EVP International Operations | Inge G. Thulin | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current 3M News
- 3M Co(GAAP) (MMM.GP) Weekly Earnings Information [Nelson Information - Weekly Domestic] (11 May 2008 04:18:00 EDT)
-
3M Co (NYSE:MMM) Weekly Earnings Information [Nelson Information - Weekly Domestic] (11 May 2008 00:59:00 EDT) - Briefing.com: Hourly In Play (R) - 00:00 ET [Briefing.com] (11 May 2008 00:00:00 EDT)
Latest Industry Video
-
ASCO 2007 Preview (5:07)
06/01/07 8:50AM ET - Wachovia Capital Markets Senior Biotech Analyst George Farmer and Miller Tabak Pharmaceutical Analyst Les Fundleyder discuss new drugs coming out at this year's conference.